TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00308113 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04493307 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01991678 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT03770338 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04596358 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02891850 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02927080 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04040478 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02118389 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01652703 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02558140 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT01595698 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03457168 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02272920 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01529255 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03684811 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT00080977 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02555189 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT05951062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03138889 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT00953446 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT03857191 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01331551 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00038857 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03030508 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02375568 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03465202 — Safety Biomarker (SAF): CDA
Genes: CDD
Study NCT01373372 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT04358029 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03543579 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00040664 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02421276 — Predictive Biomarker (PRD): AIRE mRNA
Genes: AIRE; APECED
Study NCT04919850 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02151760 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03854305 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02417701 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT02417701 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01447901 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT02563353 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04282434 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02520076 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT00438113 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01524692 — Predictive Biomarker (PRD): MYB mRNA
Genes: MYB
Study NCT02978261 — Predictive Biomarker (PRD): PTPRZ1 mRNA
Genes: PTPRZ1; HTPZP2; PTPRZ; PTPRZ2; PTPZ
Study NCT02978261 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02120534 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT02856230 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04111484 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT06098066 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04117984 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00118365 — Predictive Biomarker (PRD): ODC1 mRNA
Genes: ODC1
Study NCT02856503 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT02856503 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02856503 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02856503 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02856503 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02856503 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT00556712 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00556712 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00636142 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00902005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03839745 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01183897 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00296894 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03404557 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03026010 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00208611 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04171778 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04171778 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04171778 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02227888 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03190941 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03190941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03190941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00111384 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00111384 — Safety Biomarker (SAF): RAS pathway
Study NCT01975701 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT01975701 — Predictive Biomarker (PRD): TACC1 mRNA
Genes: TACC1; KIAA1103
Study NCT01975701 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT01975701 — Predictive Biomarker (PRD): TACC3 mRNA
Genes: TACC3; ERIC1
Study NCT00507845 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02112799 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00969995 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00987155 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00000499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00927537 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03362684 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03362684 — Predictive Biomarker (PRD): miR-31
Genes: MIR31
Study NCT04252456 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03705507 — Safety Biomarker (SAF): RAS pathway
Study NCT00989339 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00989339 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04602182 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01455337 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02286687 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00600587 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00600587 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01526473 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01570686 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02200445 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00630708 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00166647 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study NCT03123276 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05159024 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05159024 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05159024 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04671693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02890784 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01765335 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01765335 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01765335 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02429193 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02441907 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02441907 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03132155 — Predictive Biomarker (PRD): ATF1 mRNA
Genes: ATF1
Study NCT01808872 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00479960 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT01932866 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03579342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03280888 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03280888 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03280888 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03280888 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03280888 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study NCT03280888 — Predictive Biomarker (PRD): ASXL1 mRNA
Genes: ASXL1; KIAA0978
Study NCT03280888 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT03280888 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03280888 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT03280888 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT03280888 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03280888 — Predictive Biomarker (PRD): P2RY6 mRNA
Genes: P2RY6; PP2891
Study NCT03280888 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT03280888 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study NCT00997230 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02275650 — Predictive Biomarker (PRD): CYP27A1 mRNA
Genes: CYP27A1; CYP27
Study NCT02275650 — Predictive Biomarker (PRD): CYP27B1 mRNA
Genes: CYP27B1; CYP1ALPHA; CYP27B
Study NCT03656744 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT03766386 — Predictive Biomarker (PRD): LAMP2 mRNA
Genes: LAMP2
Study NCT02659306 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02322203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03122977 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06550713 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT04505254 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01976884 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00075179 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01021540 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04348695 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02326376 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT03244345 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03244345 — Safety Biomarker (SAF): BDNF
Study NCT03244345 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01974245 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01974245 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01974245 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05492617 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01572454 — Surrogate Endpoint (SUR): Serum potassium
Study NCT01654367 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04022044 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00344227 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00596570 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT02097810 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT02097810 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT02097810 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT02097810 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02097810 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01037647 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00005094 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT00429104 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03059823 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT02786251 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01096225 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01020851 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01020851 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04084457 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04475523 — Predictive Biomarker (PRD): VSIR mRNA
Genes: VSIR; C10orf54; SISP1; VISTA; PP2135; UNQ730/PRO1412
Study NCT02705846 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02705846 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT02705846 — Predictive Biomarker (PRD): HOXB13 mRNA
Genes: HOXB13
Study NCT02522026 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT01318304 — Predictive Biomarker (PRD): SLPI mRNA
Genes: SLPI; WAP4; WFDC4
Study NCT01248143 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01248143 — Safety Biomarker (SAF): Interleukin 1
Study NCT03587428 — Surrogate Endpoint (SUR): Bacterial count
Study NCT03857282 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03356353 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01209091 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01209091 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02997748 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT00194779 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00194779 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00194779 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01155973 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00834600 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT05712798 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01864681 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01864681 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02374788 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03687294 — Predictive Biomarker (PRD): MYB mRNA
Genes: MYB
Study NCT03192293 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00700882 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01621620 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02389010 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03888547 — Predictive Biomarker (PRD): MAF mRNA
Genes: MAF
Study NCT04090580 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04702334 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04702334 — Surrogate Endpoint (SUR): Bacterial count
Study NCT00822159 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03158740 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02801240 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02801240 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02801240 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02801240 — Surrogate Endpoint (SUR): Serum potassium
Study NCT02801240 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00678054 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02425956 — Predictive Biomarker (PRD): Liver iron
Study NCT01948453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04334135 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04334135 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01133756 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04300114 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT02037321 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00726804 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02157298 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04156425 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04156425 — Predictive Biomarker (PRD): PRKCB mRNA
Genes: PRKCB; PKCB; PRKCB1
Study NCT03763123 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00396591 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04472624 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT04472624 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT02041468 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02076880 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT03898141 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT00529061 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01132404 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02512237 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01785732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04189211 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02964351 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02511184 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00339430 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03627533 — Predictive Biomarker (PRD): GDF9 mRNA
Genes: GDF9
Study NCT02554812 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02455336 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02455336 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02455336 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02455336 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01939977 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT04142138 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00577707 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00577707 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02036710 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02475720 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02977689 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04461171 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT01744990 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00389363 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02635555 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05823584 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05823584 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT05823584 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05823584 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00335673 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04236011 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01458496 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02786342 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01426880 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00367094 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00390858 — Predictive Biomarker (PRD): Liver iron
Study NCT00142584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02159690 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02159690 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH